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INTRODUCTION
Tropical Calcific Pancreatitis (TCP) is the most common type in India and 
China, accounting for 60 – 70% of all Chronic Pancreatitis. This is in contrast 
with  developed  countries  where  Alcohol  related  Pancreatitis  accounts  for 
most  of the cases of Chronic Pancreatitis.  Tropical Calcific Pancreatitis is 
generally a disease of youth and early adulthood. It is found in areas with in 
30 degrees of latitude on both sides of the equator. Pancreatitis is the most 
common mode of presentation in 70 – 100% of patients. Later in the course, 
patients may present with diabetes mellitus,  maldigestion and weight loss. 
Pathologically Tropical Calcific Pancreatitis is characterized by large intra 
ductal  calculi,  marked  dilatation  of  main  duct  and  glandular  atrophy.  Its 
etiology is not known. High level of consumption of cassava which contains 
toxic  glycosides  is  attractive  hypothesis  but  not  proved  yet.  Two  recent 
studies have reported that a significant percentage of patients with Tropical 
Calcific  Pancreatitis  have  spink1  mutation  .  Endoscopic  Retrograde 
Cholangio  Pancreatography  (ERCP),  the  secretin  stimulation  test  and 
Endoscopic Ultrasound (EUS) have all been suggested as a gold standard for 
the diagnosis of Chronic Pancreatitis. The management of Tropical Calcific 
Pancreatitis involves managing pain, diabetes and steatorrhoea. 
Endotherapy has emerged as the main stay of treatment for pain. Surgery is 
an effective treatment for patients who had failed medical and Endoscopic 
therapy.  Drainage  with  lateral  Pancreaticojejunostony  is  the  most  widely 
used procedure for ductal decompression. 
 This  study  is  from  an  territory  referral  centre  for  gastroenterological, 
Hepatobiliary and pancreatic problems offering services free of cost to poor 
sections of the society. Endoscopic Retrograde Cholangio Pancreatography 
and  Endotherapy  was  done  by  a  team  of  experienced  Endoscopists  and 
assisted by residents. The records were well maintained. This forms the basis 
for this study.   
LITERATURE REVIEW
TROPICAL CALCIFIC PANCREATITIS
INTRODUCTION:
The term “tropical pancreatitis” (TP) was coined in 1955 when 
Zuidema described 18 cases of disseminated pancreatic calcification in young nonalcoholic individuals in 
Indonesia.  These  patients  were  diabetic  and  had  marked  emaciation  resembling  kwashiorkor.  Zuidema 
considered  this  entity  to  be  a  degenerative  disease  of  the  pancreatic  parenchyma  (pancreatic  cirrhosis) 
secondary to protein – calorie malnutrition[4].
Zuidema’s patients were very poor and consumed a diet deficient in calories and 
protein. Non – ketotic diabetes mellitus of a severe degree was seen in almost all (16 of 18), and insulin 
resistance  was  common.  Marked  emaciation,  parotid  gland  enlargement  and  hair  and  skin  changes 
resembling kwashiorkor were some of the striking clinical features. A similar clinical picture, but without 
calcification  of  the  pancreas,  was  noted  in  27  other  patients.  It  was  assumed that  these  patients  were 
suffering from fibrosis of the pancreas without pancreatic calculi. Nineteen of the 45 patients were less than 
21 years of age. In spite of such advanced pancreatic disease, steatorrhoea was not seen.
Tropical calcific Pancreatitis (TCP) is seen in developing countries 
which affects young people, has a relatively accelerated course and is not associated with 
alcoholism. Various names have been proposed for this entity including tropical calcific 
pancreatitis,  Afro  Asian  pancreatitis,  tropical  pancreatitis  syndrome,  nutritional 
pancreatitis  and  non-alcoholic  pancreatitis.  There  were  several  reports  of  a  similar 
syndrome  from  Asia  (India,  Ceylon,  Thailand,  Malaysia),  Africa  (Nigeria,  Uganda, 
Burundi, Zaire and Malawi) and South America (Brazil). Shaper (1960) reported a similar 
syndrome  in  patients  from  Kampala,  Uganda.  The  mean  age  of  these  patients  with 
pancreatic calcification was 29 years.  Neither alcoholism nor biliary tract disease were 
important clinical associations. The single largest series of cases of tropical pancreatitis 
reported to date is from the south western state of Kerala in India where Geevarghese and 
Pitchumoni observed this disease in endemic proportions in two major Medical College 
Hospitals of the state (Geevarghese et al 1962, Geevarghese and Pitchumoni 1966)[5,90]. 
Large numbers of patients were also reported from the state of Tamilnadu (Viswanathan 
1980)  from Orissa (Tripathi  1984, Tripathi  and Samal  1987),  and recently  from Pune 
(Yajnik 1992). TCP is the commonest form of calcific pancreatitis in Southern India [96]. 
Fig.1.1 shows the distribution  in  TCP in India.  Tropical  calcific  pancreatitis  (TCP) in 
Southern India has the highest known frequency of the disease in the world[6]. Different 
aspects  of  TCP  have  been  discussed  in  classic  reviews  (Geevarghese  1968,  1985, 
Narendranathan 1981, Pitchumoni 1984, Abu – Bakare et  al 1986, Balakrishnan 1987, 
Mohan and Alberti 1990, Mohan et al 1990, Yajnik 1990, 1992) 
DEFINITION:
TCP is a juvenile form of calcific, nonalcoholic pancreatitis found 
almost exclusively in developing countries of the tropical world. Idiopathic etiology was 
considered to be the most important diagnostic criterion of TCP. TCP is characterized by 
recurrent  abdominal  pain,  exocrine  pancreatic  insufficiency,  pancreatic  calculi  and 
diabetes. These patients are young, the calculi are larger and almost always intra ductal 
with an accelerated clinical course and there is no history of alcoholism. 
PREVALANCE:
The prevalence of Tropical Chronic pancreatitis was 1:793 (0.12%) 
and that of Chronic calcific pancreatitis 1:1020 (0.09%) according to a systematic survey 
of 6079 families in a village in Quilon district in Kerala by Balaji in 1988. The prevalence 
of TCP was found to be very high in Southern India (80 to 140 per 100000 population) 
according to a study conducted by Department of Gastroentrology, AIIMS, New Delhi, 
India [19,96]. Our centre at Madras in Tamilnadu there are between 30 to 40 new cases of 
TCP each year. An other centre in Madras reported that TCP represents 1% of all diabetic 
patients that were registered[34].Distribution of tropical chronic Pancreatitis in India is 
shown in fig1.1.  
AETIOPATHOGENESIS:
The following aetiological factors have been proposed for TCP:
Undernutrition
Cassava (tapioca) ingestion
Other dietary factors
Familial and genetic factors
Oxidant stress
Miscellaneous factors
Undernutrition:
Protein calorie malnutrition is present in many TCP patients and the role of undernutrition in the aetiology 
of TCP has been elegantly reviewed by Balakrishnan (1987) and Rao (1984)[8,94].  However, malnutrition 
could well be the effect rather than the cause, because calcific pancreatitis with consequent maldigestion and 
malabsorption could itself lead to protein calorie malnutrition.  There are large pockets of malnutrition with 
relative infrequency of TCP, for example, Ethiopia (Lester 1984).  This suggests that malnutrition by itself is 
unlikely to play an aetiological role.  Thus the exact role of undernutrition in the aetiopathogenesis of TCP is 
far from clear.
Cassava: 
The  geographical  distribution  of  TCP  coincides  with  the  areas  of   consumption  of  cassava  (tapioca, 
manihot), a root consumed in tropical countries.  Cassava is known to contain the cyanogenic glycosides 
linimarrin and lotaustralin.  Cyanide is normally detoxified in the body by conversion to thiocyanate.  This 
detoxification  requires  sulphur  which  is  derived  from  sulphur-containing  amino  acids.   McMillan  & 
Geevarghese  (1980) showed that  ingestion of cyanide led to transient  hyperglycaemia in rats[5].   They 
concluded that their results supported a role for cyanide in the aetiopathogenesis of TCP.  It must however 
be noted that none of the rats in the above experiments developed permanent diabetes.  Moreover the effects 
were seen only with potassium cyanide and not with cassava.  Thus the relevance of these experiments  to 
the human situation is far from clear (Pitchumoni 1984).  
Finally, Teuscher et al (1987)  did not find any evidence of TCP in a rural West African population on a 
high cassava diet.  While the cassava hypothesis might explain the occurrence in other areas where cassava 
is consumed,  the possibility exists that other foodstuffs such as sorghum, ragi, jowar or certain varieties of 
peas may contain cyanide[28].
Other  dietary factors:
Detailed studies on the dietary intake of TCP patients have been reported by Balakrishnan et at (1988).  It 
was found that the protein intake in TCP patients was 53g/day, which was the same as controls.  The fat 
intake of TCP patients and also of controls was very low  in India (27g/day).  It was concluded that a low fat 
intake could be one of the factors responsible for the occurrence of TCP.
Familial and genetic factors:
Pitchumoni & Geevarghese (1970) were the first to report on a large series of familial cases of TCP.  They 
found 17 families where every other member had evidence of pancreatitis.  The authors were unable to 
demonstrate any definite mode of inheritance in these families.  Geevarghese (1985) has reported that about 
8% of his TCP cases show evidence of familial aggregation.  Familial aggreagation has also been reported 
by Balakrishnan (1984)[94].
Mohan et at (1989) have also reported familial aggregation in TCP.  They found that, in some families, there 
was evidence of vertical transmission of the disease form the parents to the offspring; in other families there 
was a horizontal distribution among siblings.  Familial occurrence suggests, but does not necessarily prove, 
a  hereditary aetiology for  TCP.  Several  family members  could be exposed to  the same environmental 
factors.  However, a study from a group looking at gene makers has suggested for the first time a genetic 
basis for TCP (Kambo et al 1989)[97].
Micronutrient deficiency and oxidant stress:
Calcific  pancreatitis  in  Caucasians  has  been  linked  to  heightened  oxidative  detoxification  reactions 
conducted by cytochrome P450-I within the pancreas and/or liver (Braganza 1988).  Several factors may be 
involved,  including  calcific  induction  of  the  cytochrome  P450-I  subfamily  of  mono-oxygenases  by 
xenobiotics (cigarettes, alcohol, occupational chemicals, dietary corn oil. Etc.,).
Further studies by Chaloner et al (1990) revealed that theophylline clearance ( a measure of cytochrome 
P450-I  activity in  vivo) seems to be faster  in TCP patients  compared  to  controls.   This  suggested  that 
oxidant stress may be playing a role in causation of TCP.  Studies on antioxidant  status of TCP patients 
showed low levels of vitamin C and beta-carotene (Mohan & Braganza 1991).   This could also tilt  the 
balance in favour of oxidant stress.  These studies suggest that there could be common aetiological factors in 
temperate-zone and tropical forms of calcific Pancreatitis. A unifying hypothesis  for alcoholic and tropical 
pancreatitis was proposed by Pitchumoni et at (1988).  Perhaps in a background of genetic susceptibility to 
the disease, toxic factors in the diet may produce pancreatic injury leading to the endocrine and exocrine 
damage, thus accounting for diabetes and exocrine pancreatic dysfunction (Mohan et al 1991).
PATHOLOGY:
The pathology in pancreas in TCP has been described in detail by 
Geevarghese (1985) and Nagalotimath (1980)[5]. The pancreas is small, firm, fibrous and 
gritty to touch. Calculi  of varying sizes and shapes may be detected in the ducts. The 
histopathology is quite characteristic with dilatation of the main ducts, pancreatic lithiasis, 
calcific inflammatory cell infiltration, fibrosis and atrophy of the parenchyma. Denudation 
of the ductal epithelium and squamous metaplasia may also be seen. Interlobular fibrosis 
is characteristically seen in early cases and focal, segmental or diffuse inter acinar fibrosis 
in  more  advanced  cases.  Islet  cells  are  virtually  absent  but  may  occasionally  be 
hypertrophied.
ANALYSIS OF STONES:
Stones consist of almost pure calcium carbonate. Pitchumoni et al 
(1987)  have  analysed  the  composition  of  pancreatic  stones  by  X-ray  diffractometry, 
scanning electron microscopy and energy-dispersive X-ray fluorescence[94]. They found 
that the nidus of the stone contains iron, chromium and nickel, whereas the outer shell 
contains calcium and 17 other elements. It is of interest that, irrespective of the aetiology 
of calcific pancreatitis, the structure and composition of pancreatic calculi are the same, 
suggesting  a  common  path  way  for  lithogenesis  in  TCP  and  Alcoholic  chronic 
pancreatitis(ACP) patients revealed that the organic matrix contain one major pancreatic 
stone protein (PSP;Mol.Wt 15000) and a minor protein (Mol.Wt 30,000), the latter being 
an aggregate of the former. The presence of PSP in stones obtained from patients with 
TCP and ACP suggests that it may play a key role in stone formation during the course of 
calcific pancreatitis of either aetiology[28]. PSP has now been renamed Lithostathine in 
view of its normal function of retarding calcium carbonate crystal growth.
CLINICAL FEATURES:
TCP is a disease of youth and the mean age at diagnosis of pancreatitis is 20 years.  Over 90% of patients 
have onset below 40 years (Geevarghese 1968).  Most hospital-based studies have reported a marked male 
predominance but Balaji (1988) found a slight female predominance in his population survey.  Patients are 
invariably  poor  and  present  with  extreme  emaciation,  protein  calorie  malnutrition,  bilateral  parotid 
enlargement and distension of the abdomen.  Geevarghese (1968) has described a peculiar cyanotic colour of 
the lips but this is rarely seen in our patients.  Growth is often retarded and multiple vitamin deficiencies and 
skin infections  may be  present.  The  natural  history  of  the disease  has  been  succinctly  summarized  by 
Geevarghese (1968) as abdominal pain in childhood, diabetes in youth and death at the prime of life[5]`.
Patients are often symptomatic for years before the diagnosis is established. The mean 
time  from  the  onset  of  symptoms  to  diagnosis  of  TCP  is  62  months.Though  most 
individuals are lean, some are with a normal BMI or even obese. Typically, patients with 
TCP manifest with a triad of symptoms  abdominal pain, maldigestion, and diabetes.
,
Abdominal pain
The frequency of abdominal pain varies from 30% to 95% in different series (Ramachandran et al 1969, 
BalaKrishnan 1984). The typical pancreatic pain is upper abdominal in location, may radiate to the back. It 
is initially severe,  recurrent  and episodic. The pain is usually aggravated by food. Abdominal ileus is a 
common accompaniment of this pain. In Geevarghese`s series 95% of patients had pain in the abdomen with 
radiological evidence of pancreatic calculi[5].
The precise mechanism underline the abdominal pain is uncertain. It may be related to an 
inflammation  of the pancreas,  increased intra  pancreatic  pressure due to an obstructed 
pancreatic  duct  secondary  to  stenosis  or  calcification,  neuroinflammation  or  as  a 
complication  of the disease such as pseudocyst  and obstruction of biliary or duodenal 
drainage. It tends to become milder and less frequent as the disease progresses over 10-25 
years. 
Exocrine insufficiency & Steatorrhea
The frequency  of  steatorrhoea  is  low because  of  the  low fat  intake  in  the diet.About  20% of  patients 
complain of passing bulky, frothy or frank oily stools. If the fat intake is increased to about 100g day, over 
70% of patients have demonstrable steatorrhoea(Pitchumoni 1984,Geevarghese 1985)[5,90]. Approximately 
90%  of  the  exocrine  pancreas  must  be  destroyed  before  significant  steartorrhoea,  azotorrhoea  and 
creatorrhoea occur[20,21,23]. Fat maldigestion is more severe than protein and carbohydrate maldigestion. 
This  is  because  lipid  depends  only  on  pancreatic  lipase  and  co-lipase  for  digestion.  Bicarbonate 
insufficiency causes reduced intraduodenal pH which is more injurious to lipase. Steatorrhoea is corrected 
even if 10% of the normal amount of lipase can be delivered at the proper time. Although maldigestion 
affects all  nutrients, the most clinically significant  problem concerns maldigestion of fat and fat-soluble 
vitamins. 
Endocrine insufficiency
Diabetes mellitus develops when more than 80% of the gland has been destroyed. The diabetes is often 
complicated by hypoglycaemic episodes caused by an inadequate glucagon response during insulin therapy.
Diabetes  is  an  invariable  consequence  of  TCP.  The World  Health  Organization  study group  report  on 
diabetes mellitus (1985) has classified the form of diabetes secondary to TCP as a separate entity called 
fibrocalculous pancreatic diabetes (FCPD) under the broad category of malnutrition related diabetes mellitus 
(MRDM).
Diabetes  is  usually  severe  with  fasting  blood  glucose  levels  between  200  and  400  mg/dl.  One  of  the 
characteristic  features  of  this  form  of  diabetes  is  that,  despite  requiring  insulin  for  control  of 
hyperglycaemia, patients rarely become ketotic. Mohan et al (1985) have shown that the response to therapy 
is dependant on pancreatic beta-cell function[98]. Patients who have some residual beta-cell function as 
shown by significant serum C-peptide levels may respond to oral hypoglycaemic agents and / or diet. At the 
other end of the spectrum are patients with absent or negligible C-peptide level and they may indeed be 
prone to ketosis. The majority of patients have enough beta-cell reserves to protect them against the ketosis 
but not sufficient to respond to oral agents. 
Insulin resistance, defined as a daily insulin dose in excess of 200 units/ day is often described as a feature 
of this disease (Geevarghese 1968, WHO study group on diabetes mellitus 1985). The mean requirement of 
insulin dose was 40 + 12 units per day. FCPD is a secondary form of diabetes and diabetic complications 
such as retinopathy,  nephropathy and neuropathy occur during long-term follow-up (Mohan et  al  1985)
[11,98]. Macro vascular complications (Ischaemic heart  disease and peripheral  vascular disease),  though 
rare, do occur (Mohan et al 1989). The relative infrequency of the Macro vascular complications are due to 
the younger age of the patients, leanness and the low serum cholesterol levels (Mohan et al 1985).
Malnutrition & Weight Loss:
This  occurs  initially  due  to  a  decreased  caloric  intake  secondary  to  the  fear  and 
anticipation  of  abdominal  pain  (Postprandial  exacerbation  of  pain)  and  later  due  to 
pancreatic  exocrine  insufficiency,  maldigestion  of  fat,  azotorrhoea,  carbohydrate 
maldigestion, diabetes mellitus and malignancy. 
Biliary Obstruction & Jaundice:
It  is  reported  in  10%  of  TCP  patients.  Jaundice  may  occur  due  to  biliary  stricture 
secondary to inflammation of the pancreatic head or due to obstruction by a super imposed 
pseudocyst or malignancy[34].  
Other common symptoms include nausea, vomiting, constipation, flatulence and bloating.
Rarely, patients may present with an abdominal mass, ascites or gastrointestinal bleeding[28,31,79].
Complications: 
Multiple  complications  may be  present  in  TCP.   The  presence  of  diabetes  leads  to  increased 
frequency of pulmonary tuberculosis and fungal, skin and urinary tract infections (Pitchumoni 1984). Severe 
pyorrhea, gingivitis and bilateral cataracts are frequent associations. Hepatomegaly is common and cirrhosis 
of  the liver  may coexist.  Obstructive jaundice  is  occasionally seen[35,36].  This is  attributed to  fibrosis 
involving the common bile duct or associated carcinoma of the pancreas[28].
Recently it has been observed that the frequency of carcinoma of the pancreas is very high in patients with 
TCP (Chari et al 1993). Initial studies suggest that the incidence of carcinoma in TCP may be higher than 
that noted in temperate zone pancreatitis[25].The incidence of pancreatic malignancy was reported as 8.6% 
(Philip Augustine 1986). 
Addiction to Narcotics is a serious potential complication of TCP. Chronic pain with recurrent exacerbations 
is quite common. (Refer Table 1.6).
Investigations:
Serum amylase levels are usually within normal limits (Balakrishan 1984, Pitchumoni 1984). Occasionally 
the amylase levels may be elevated during an acute exacerbation of pain. In advanced stages of the disease 
the levels may be low. Serum lipase levels are generally low. Both serum cholesterol and triglyceride levels 
tend to be low (Mohan et al 1985 )[98]. Serum total protein and albumin, serum calcium and phosphorus 
levels are all within normal limits. Serum Iron and D-Xylose absorption are normal.
Exocrine Pancreatic Function:
The  paucity  of  data  on  exocrine  pancreatic  function  in  TCP  is  mainly  due  to  unpleasantness  and 
inconvenience of the older pancreatic function tests (Stool fat and tube tests). Recently, measurements of 
specific  pancreatic  enzymes  (Serum  and  immunoreactive  trypsin)  showed  the  spectrum  of  exocrine 
pancreatic  involvement (Yajnik et  al 1989 )[29]. In  early cases Serum immunoreactive trypsin was sub 
normal in most cases and severely diminished in over two thirds. Stool chymotrypsin measurements showed 
similar results (Mohan et al 1989, Yajnik et al 1990).
The Secretin-Pancreozymin test in a small number of patients showed that pancreatic enzyme output was 
severely  diminished;  trypsin  was  more  affected  than amylase  (Tripathy 1984,  Tripathy & Samal  1987, 
Punnose et al 1987). Balakrishnan and colleagues (1988) made the interesting observations that even some 
of the control subjects from south India showed evidence of early Pancreatopathy. Yajnik also observed 
elevated  Serum  immunoreactive  trypsin  concentrations  in  our  population  in  the  absence  of  clinical  or 
radiological evidence of TCP. It is possible that a subclinical pancreatopathy occurs in the tropics which 
may have an environmental aetiology and that the full -blown picture of TCP with calculi is the extreme end 
of the spectrum (Yajnik  et al 1990)[29].
Endocrine Investigations:
Several studies have attempted to explain the ketosis resistance exhibited by patients with FCPD. Mohan et 
al (1983) measured C-Peptide levels in these patients. It  was found that patients with FCPD had partial 
preservation  of  pancreatic  beta-cell  function.  In  contrast,  patients  with  classical  ketosis-prone  Insulin-
Dependant diabetes mellitus had negligible beta-cell reserve. It  was therefore concluded that the residual 
beta-cell  reserve may be responsible for preventing ketogenesis  in these patients. Recently Mohan et al 
(1990)reported  that  defective  pancreatic  glucagon  secretion  is  responsible  for  ketosis  resistance[98]. 
Glucagon one of the primary hormones responsible for ketogenesis, and an absent glucagon response could 
protect against ketoacidosis.
Yajnik et al (1990b) measured beta-cell function in TCP patients with different degrees of glucose tolerance. 
Plasma C-Peptide concentrations  (A marker  of  pancreatic  beta  cell  reserve)  were  normal  in  those  with 
normal or mildly impaired glucose tolerance. In a diabetic group (FCPD) plasma C-Peptide concentrations 
were widely scattered; in about 75 % they were severely diminished, indistinguishable from type 1 diabetic 
patients. Interestingly, none of these FCPD patients had presented with ketosis, suggesting that other factors 
in addition to beta-cell function may be involved in the ketosis resistance shown by these patients[29].
Pancreatic Imaging:
1. Plain Roentgenogram:
Plain  radiographs  (fig.1.2)  of  the  abdomen  reveal  diffuse  or  local  pancreatic 
calcification  in  72%  to  97%  of  patients  with  TCP  and  in  about  30%  of  patients  with  alcoholic 
Pancreatitis[3]. TP is characterized by the frequent occurrence of large, discrete, dense calculi, patients with 
alcoholic pancreatitis  has typically small, speckled calculi  with irregular  hazy margins.  The stones may 
reach a large size of (4.5 cm) in diameter and have dumbbell- shaped extensions into the side branches that 
are  difficult  to  remove  at  surgery[7,9,13].  Clearance  of  these  staghorn-shaped  calculi  from  the  main 
pancreatic  duct  seems to  be necessary to  allow free  drainage  of  the  side branches  into the main duct. 
Progressive displacement of calculi on serial plain radiographs may provide a clue to the presence of either 
an enlarging tumor or a pseudocyst in a patient with underlying CP[19]. 
2.Ultrasonography:
Ultrasonography helps to confirm the location of the calculi within the pancreatic duct. The pancreas is often 
reduced in size in patients with TCP. Additional features noted on ultrasonography are ductal dilatation, 
fibrosis of the gland and irregular gland margins (Mohan et al 1985b). The most common USG sign was a 
‘dilated  pancreatic  duct’[13].  Other  findings  included  demonstration  of  calculi,  increased  echogenecity, 
pancreatic atrophy.  USG findings in TP differ from the calcific  alcoholic pancreatitis seen in the West; 
pancreatic calculi, pancreatic atrophy and duct dilation being commoner in TP (table 1.5)
The MPD is  frequently  visualized  at  ultrasound  examination.  However,  body 
habitus and the presence of gas can occasionally frustrate sonographic interrogation. It is best seen in the 
mid  body of the pancreas on transverse scans. Here the main duct is relatively anterior in location as it 
courses over the spine[15]. The duct is depicted by parallel ecogenic walls on either side of a relatively 
anechoic lumen. The normal side branches are usually not visualized, except for the occasional appearance 
of the larger uncinate branches in the pancreatic head. The MPD’s diameter is less than that found at ERP. 
Ultrasound  also  probably  under  estimates  the  duct’s  diameter  because  of  the  apparent  mural  thickness 
imparted by the ecogenic duct wall. Guidelines for average diameters of the head, body and tail have 
been reported as 3.0, 2.1, and 1.6 mm respectively[17].
3. Computed Tomography:
Computed tomography is also useful and the delineation of the pancreas is very good. However it is too 
expensive for routine use. The MPD is usually visualized on abdominal CT. The duct is displayed as a fine 
tubular  structure  of  water  attenuation,  which  can  be  followed  over  a  variable  distance  against  the 
background of the enhanced pancreatic parenchyma. As with the ultrasound, the normal side branches in the 
body and tail are not seen, but the occasional uncinate branch in the pancreatic head and the acessory duct 
may be visualized[13]. 
In TCP, the abdominal CT usually reveals irregularity of the contour on the gland, dilation of pancreatic 
duct and presence of calcification in patients with uncomplicated Pancreatitis[55]. CT is a useful adjuvant, 
particularly in detecting associated malignancy and to characterize the pseudocysts just prior to surgery. CT 
is superior to plain radiographs in detecting pancreatic calcification and to US in detecting pseudocysts with 
their anatomic relationships. CT and ultrasound are useful in instances where the MPD cannot be shown by 
ERCP due to the presence of large intraluminal calculi in pancreatic head causing an obstruction.  
 ENDOSCOPIC RETROGRADECHOLANGIO 
PANCREATOGRAPHY(ERCP):
                   ERCP remains the imaging method of choice in patients with suspected 
pancreatic disorders. ERP is mandatory in patients with TCP when surgical intervention is 
indicated.  ERCP is indispensable in the differential diagnosis between inflammatory and 
new dysplastic changes within the pancreas. 
Main Pancreatic Duct:
MPD has an S-shape contour with the straightened extension of the superior curve that course toward the 
left upper quadrant.  The shoulder of the S-shape is called The “Neck”, the “Isthmus”, or the “Knee”.  The 
body of the pancreatic Duct extends from the Neck to the left border of the Vertebral Body, while the tail 
continues left ward to its termination.  The MPD averages 16 to 17 cm in length (10-25 cm).  The tail  
frequently ends in a terminal bifurcation to signal complete MPD opacification.  The tail of the MPD is 
designated as proximal, or up-stream, while the head is distal, or downstream.  The S-shape configuration, 
along with visualization of side branches,  differentiates  the MPD from the CBD(fig1.3).   Occasionally, 
however, instead of an S-shape, the MPD contains a loop or spiral near the Duct Neck.  
The diameters along the MPD vary because of its-tapered configuration.   The normal 
Pancreatic  Duct  diameters  for  the  head,  body and tail  are  3.5,  2.5  and 1.5  mm, 
respectively[46,54,57,58].  However the upper limits of the normal are more generous- 
6.5, 5.0 and 3.00 mm, respectively.   The normal Pancreatic Duct usually empties by 5 
minutes after injection of contrast  and over 10 minutes is considered abnormal.  
Side Branches:
Quantifiable criteria for the pancreatic duct’s side branches do not exist[18,93].  There is 
no standard number of standard pattern of branches arising from the MPD and number 
universally accepted side branch diameter  or length.  More important than a definable 
number of side branches is the periodicity of the branch points. This regular interval is 
usually constant in the body and tail of the MPD.  The side branches should join at a 
reproducible interval.  Whether the branch from the MPD at a right angle or at an acute 
angle,  or  join  immediately  opposite  each  other  or  alternate,  the  pattern  is  usually 
constant[52].
The side branch itself is a delicate, ductal structure that begets its own branches.  It should 
gently taper as it courses into the parenchyma, being of widest dimension at its mouth. 
All  the  body and tail  branches  should  appear  uniform;  however,  the  presence  of  two 
ectatic branches may still be considered normal.  The side branches of the pancreatic head 
course inferiorly from the MPD to serve the uncinate process.  This duct network consists 
of a dominant single branch with its own compliment of side branches or it may have a set 
of similar size the branches that fan out to cover this territory.
The second dominant side branch of the pancreatic head is the accessory duct, or the duct 
of  Santorini.   In  50  to  70%  of  cases,  this  duct  maintains  communication  with  the 
duodenum, draining through the minor papilla located 1 to 2 cm cephalad from the major 
papilla  on  the  medial  duodenal  wall.   In  1/3rd of  cases,  the  accessory  duct  loses  its 
connection with the duodenal, being relegated to serve as just another side branch off the 
MPD.  Another variation in the side branch pattern is the occasional dominant branch off 
the body of the MPD that parallels parent duct as they course upstream[54].  In some cases 
it creates the appearance of a bifid or duplicated system.
ERCP in Tropical Calcific Pancreatitis:
ERCP is the best diagnostic method in patients with suspected TCP when the morphology 
of the pancreatic ductal system is of interest.  This is particularly important when there is a 
possibility of co existent or associated biliary tract disease and when pancreatic surgery is 
contemplated[51].  The main diagnostic problems, as noted, arise in relation to recognition 
of  minimum degrees  of TCP and in the  differential  diagnosis  of  chronic  pancreatitis 
verses pancreatic carcinoma[25,38].
TCP  causes  a  wide  variety  of  morphological  changes  in  the 
pancreatic ductal systems that are demonstrable by ERP(fig1.4). ERP provides important 
information concerning the functional status of the pancreas, the prognosis, the need for 
further  therapy and the types  of treatments  that  may be beneficial.  There is  a general 
correlation  between  the  number  and  the  types  of  ERP  findings  and  the  severity  of 
TCP[11,18]. 
A  system  for  staging  ERP  finding  in  Calcific  Pancreatitis  was 
proposed  by  Kasugai  et  al  in  1972[53].  According  to  the  system,  three  categories  of 
chronic Pancreatitis were recognized by ERP. They are minimum, moderate and advanced 
(also referred to as grades I, II and III, respectively). In minimum CP, the radiographic 
findings  are  restricted  to  MPD  branches  and  sub-branches  and  consist  of  irregular 
distribution,  dilation,  stenosis,  and  Obstruction.  In  moderate  CP,  the  changes  of  mild 
degree are present but to a more advanced degree, and in addition, there may be cystic 
dilation of the MPD branches and also tortuosity, dilation, and stenosis of a mild degree of 
the MPD. In advanced Pancreatitis, all of the findings cited above are present in a more 
severe degree, and in addition, there may be obstruction or dilation of the MPD to cystic 
proportions   (fig.1.5).
In 1984 the system for the Pancreatographic diagnosis of CP was 
set  forth  at  the  Cambridge  International  Workshop  on  Pancreatitis.  Terminology  and 
definitions for Pancreatographic abnormalities that arise in CP proposed at this conference 
have been summarized by Axon et al [1,52].
Assessment  of  MPD  branches  has  pivotal  importance  in  the 
Cambridge  classification  although  this  assessment  is  largely  subjective.  Abnormalities 
include  a  decrease  in  number  (which  may be  focal,  multifocal  or  diffuse),  shortened, 
dilated, narrow and irregular contour. The term parenchymal opacification is preferable to 
acinarization,  acinar  opacification  and acinar  filling.  This  can  be described  as  coarse, 
smooth or early. Axon et al recommended the terms Upstream (i.e., in the direction of the 
tail of the gland), in referring to proximal portions of a duct and downstream, to signify 
ductal segments nearest the duodenum. If the main duct diameter exceeds 1 cm, dilation is 
said to be severe.  A localized narrowing less than 5 mm in length is  referred to as a 
stricture.  If  there  are  multiple  strictures,  the  duct  is  said  to  be  severely  irregular. 
Obstruction is premature termination of the MPD; this may be described as abrupt, tapered 
or irregular. Intraductal filling defects is a preferred term for stones and calculi. A non-
ductal space that fills with a contrast is called a cavity. These may be large (> 10 mm in 
diameter) or small. Pancreatograms in CP are graded in the Cambridge system as normal 
or equivocal  or as demonstrating mild,  moderate,  or marked changes,  either diffuse or 
local (Table 1.1). The changes that were observed for assessing the severity or degree of 
CP based on Pancreatographic findings is presented (Table 1.2 and 1.3). 
Heij et al compared ERP (Kasugai classification) and the results of 
Pancreatic function testing with secretin-cholecystokainin stimulation in 69 patients.  In 
86% of the patients, the results of the two tests were rated as comparable [2]. In some 
patients with CP, ERCP may fail to opacify the pancreatic duct. This can be due to faulty 
technique,  stenosis  or  obstruction  of  the  MPD  near  the  main  duodenal  papilla.  The 
presence of long, distally tapering, smooth structure of distal CBD suggests the presence 
of advanced calcific pancreatitis. 
The visualized filling defects within the pancreatic duct may be due 
to  muco  proteinceous  substance  or  calcium  carbonate  stones.  The  muco  gelatinous 
substance may be a prominent finding at the ERP and can cause ductal obstruction, which 
can be removed with manipulation[25,33]. 
ENDOSCOPIC ULTRASONOGRAPHY (EUS):
             This  is  highly accurate  in establishing the diagnosis  of TCP and calcific 
Pancreatitis in general. EUS identifies both parenchyma and ductal changes. It has been 
used successfully in characterizing malignant pathology in TCP. EUS may be useful in 
following situations[87].
1. Equivocal CT findings for mass lesions (EUS-FNAC).
2. To delineate a local extension of malignant mass.
3. Technically unobtainable pancreatograms.
4. To identify the cyst and major vascular structures prior to Endoscopic drainage of 
pseudocysts.
5. Identification of small pseudocysts (less than 1 cm) or masses not identified by 
conventional imaging methods.
MAGNETIC RESONANCE CHOLANGIO PANCREATOGRAPHY (MRCP):
          The main advantages of MRCP are non-invasive visualization of the biliary duct and pancreatic duct 
without injection of contrast, with no pre procedural preparation and no radiation to patients. It  uses fast 
heavily T2-weighted pulse sequences to evaluate water containing structures such as gall bladder, bile ducts 
and pancreatic ducts. Thick slices can be obtained in a plane parallel to either the CBD or MPD so that the 
entire duct structure is depicted. Intra luminal filling defects, such as calculi are readily detected. MRCP is 
superior to CAT scan at depicting dilatation and beading of the MPD and may reveal calculi as intra luminal 
filling defects[22]. Like CAT scan, the sensitivity to side branch changes is much lower. Indications for 
MRCP included patients with surgical diversion of the stomach and duodenum, patients in whom it is not 
possible to opacify the duct  proximal to an obstructing lesion and patients who are unlikely to require 
intervention during ERCP. Any cystic structure close to the pancreatico biliary tree will appear on MRCP 
whether or not it communicates[50]. 
MANAGEMENT:
Medical Management:
Medical control of pain
The main stay of treatment is analgesics. As the pain is  continous and severe, there is a fine line between 
adequate  analgesia  and  addiction[20].  Therapy  may  be  initiated  with  acetaminophen  or  NSAIDS. 
Acetaminophen is given in the dose of 650 mg/po q 4 hr; dose and should not exceed 4000mg/d. Addition of 
Anti depressant such as amitriptyline hydrochloride in the dose of 25 to 75 mg PO qd may be helpful.
Pancreatic enzyme supplements are used for relief of abdominal pain and reducing symptoms related to 
steartorrhoea[44]. 
Hormonal therapy:- Octreotide is an 8 amino sequence containing the active portion of somatostatin. It is 
given as sub cutaneous injection in a dose of 50 to 200 micrograms tid before each meal. In a study by 
Toskes et al when compared with placebo the response to pain relief was 65% v 35%. 
Celiac nerve block:- it can be done through percutaneous route under CT guidance and alcohol is injected to 
destroy the nerves around pancreas.
EUS guided Celiac plexus neurolysis:- It is first described in 1995. A linear phased array echo endoscope is 
passed into the stomach. The Celiac plexus is identified and a needle is positioned just lateral to the take off 
of the Celiac trunk, flushed, aspirated and injected with the local anaesthetic in combination with either 
steroid or absolute alcohol. In a study of 90 patients, Gress et al reported 55% improvement in pain score 
were seen. 
Enzyme replacement therapy:- Pancreatic enzyme supplements are the main stay of therapy of TCP[44]. 
The goals of treatment with pancreatic enzymes in patients with TCP are two fold:
Pain relief 
Control of maldigestion caused by exocrine pancreatic insufficiency
Pancreatic enzyme therapy is clinically given with the appearance of loss of body weight, steartorrhoea with 
stool fat excretion more than 15 gms per day, dyspeptic symptoms with strong meteorism, diarrhoea and in 
rare cases with the appearance of maldigestion of protein and carbohydrates and for the treatment of pain. 
Atleast  25000-30000  U of  lipase  per  meal  are  necessary  for  adequate  lipolysis  to  alleviate  pancreatic 
steatorrhoea[20,44].
Dosage:  2-3  enteric-coated  capsules  or  4-8  non-enteric  tablets  after  each  meal.  The  capsules  and 
minimicrospheres should be swallowed whole, without crushing or chewing. Treatment of pain is facilitated 
by the use of high  protease enzyme containing  preparation.
 Future prospects: Recent scientific development such as the characterization of an acid  stable bacterial 
lipase, the cloning of human acid  stable lipase, the transfection of human lipase genes by virus  mediator 
gene transfer and the development of very small acid  stable lipase. 
Adverse  effects:  Nausea,  vomiting,  bloating,  cramping,  constipation,  diarrhoea,  allergic  reactions, 
hyperuricemia.  In  children with cystic  fibrosis,  fibrosing colopathy (strictures  in right  colon, fibrosis in 
terminal ileum) have been reported. 
Control of Diabetes:- 
                                The interval between onset of Pancreatitis and diabetes is reported to be an average of  
9.1 years by a study from Kerala[89]. Diabetes in TCP presents most often in the third decade. The blood 
sugar level fluctuates very widely leading to episodes of hypoglycaenia.  Nearly half the patients can be 
controlled on oral hypoglycaemic agents. Insulin resistance develops in 25% of the cases. Macro vascular 
complications are rare. Neuropathy seems to be a common feature. Most often TCP patients are non ketotic 
despite being insulin dependant[98]. 
Surgical Management:
The  surgical  management  of  TCP  has  been  reviewed  by  Varghese  (1980). 
Pancreatic drainage procedures have been found most useful in patients of tropical pancreatitis who have 
dilated ducts[63]. The drainage procedures include the following:
Pancreaticojejunostomy:
The  Puestow-Gillesby  procedure  is  the  most  frequently  used  drainage 
operation[61]. The choice is reasonable because, in order to clear the main duct of stones, the pancreatic 
duct has to be opened along its length[64]. Cysts located in the head or in the tail can also be brought into 
communication with the Pancreatojejunal  anastomosis[61].  The Duval type of pancreatojejunostomy has 
been performed by some authors but others feel that this procedure is not suitable for cases of Tropical 
Pancreatitis[26]. 
Pancreatogastrostomy:
The results of this procedure are excellent; however, it is difficult to evaluate the 
advantage of Pancreatogastrostomy per se because it has been combined with postcoeliac neurectomy. The 
operation is easier to perform than pancreatojejunostomy and is also more easily undone if, at a later date, a 
reoperation becomes necessary. It also has the theoretical advantage of bathing the pancreatic duct in acidic 
secretion  free  from  pancreatic  enzyme  activators.  This  could  prevent  a  flare-up  of  pancreatitis  in  the 
immediate postoperative period[27]. 
Transduodenal sphincteroplasty:
The abnormalities of the pancreas in tropical pancreatitits affect the whole gland; 
surgeons  were  quick  to  realize  that  Transduodenal  sphincteroplasty  is  grossly  inadequate  to  drain  the 
pancreatic duct[26,27]. 
Its  use in patients with Tropical  pancreatitis  is  confined to tackling lower-end 
common bile duct strictures, or combining with pancreatojejunal anastomosis when it was thought that the 
pancreatic duct in the region of the head of the pancreas could not be adequately drained retrogradely. 
Pancreatic Resections:
Major resections have not been widely employed as a primary surgical procedure 
in Tropical pancreatitis[19]. The reluctance of most surgeons to perform major resections is based on the 
fact  that  the patients are  usually young,  not  addicted  to  alcohol,  and control  of  diabetes  often requires 
massive doses of insulin. 
Partial  left-sided  pancreatic  resection  involving  removal  of  25-50%  of  the 
pancreas has frequently been combined with a drainage procedure in patients with Tropical pancreatitis, the 
usual indications being presence of a mass or such severe distortion of the ductal anatomy in this area that 
adequate drainage was not technically possible.
Recurrence of  pain after surgery.  Recurrent  pain after  drainage  procedures  in 
patients with Tropical  pancreatitis  has often been reported.  Stenosis of the anastomosis,  retained calculi 
causing cysts or abscesses and internal post operative herniations sometimes twisting the Roux loop used for 
the pancreatojejunal anastomosis are some of the causes identified for recurrence of pain[60]. Tumors are, 
however,  the  most  important  condition  to  be  excluded  in  any  patient  with  persistent  or  recurrent  pain 
following a drainage procedure in Tropical pancreatitis[25,26].
ENDOSCOPIC THERAPY IN TROPICAL CALCIFIC PANCREATITIS
                    Therapeutic ERCP does not stand apart from diagnostic ERCP. One is an extension of the other.  
Endoscopic  therapy is  being applied in  the setting of  TCP patients  presenting with pain,complications, 
and/or clinical  episodes of acute Pancreatitis[30,31,32,78]. One of the aims of Endoscopic therapy is to 
alleviate the obstruction to exocrine juice flow. Endoscopic drainage is appealing in that it may offer and 
alternative to surgical drainage. Table 1.7 lists the available Endoscopic techniques and their complications.
Pancreatic ductal strictures:
               Strictures of the main pancreatic duct may be a consequence of generalized or focal  inflammation 
of  necrosis  around  the  main  pancreatic  duct.  Outflow  obstruction  may  be  caused  by  ductal  strictures, 
pancreatic stones, pseudocysts and papillary stenosis. Various Interventional Endoscopic procedures on the 
pancreatic  duct  have  been  attempted  with  variable  success[99].  Dilatation  of  ductal  strictures  can  be 
performed using dilators or balloons. Most often dilatation is followed by plastic stent placement across the 
stricture  to  ensure  the  patency.  Dominant  pancreatic  strictures  can  be  treated  by  Endoscopic  stent 
therapy[72]. The success of this procedure has been reported to be 70% - 100%. Pain relief occurs in 55% - 
100% of patients when followed for 2 – 69 months[12,51]. The best candidates for stenting are patients with 
distal stricture (in the pancreatic head) and upstream dilatation (type IV Pancreatitis). Most patients with the 
stricture have associated calcified pancreatic stones. For better results, the therapy must address both the 
stones and the stricture[60,63,70] 
Pancreatic stents
They are standard polyethylene Amsterdam stents with extra side holes at 1 cm intervals to permit side 
branch juice flow. A pancreatic sphincterotomy is performed to facilitate placement of stents[65].  A guide 
wire must be maneuvered upstream to the narrowing. The diameter of the stent should not exceed the size of 
downstream duct. 5- to 7- French (Fr) stents are used in small ducts. 10- to 11- Fr stents can be used in 
patients with advanced calcific Pancreatitis and grossly dilated ducts[72,73,74]. 
Complications due to pancreatic stents are listed in Table 1.8.
Pancreatic ductal stones:
The rational for intervention is based on the premise that pancreatic stones increase he intra duct pressure 
and so the parenchymal pressure with the resultant pancreatic ischemia proximal to the obstructed focus. 
The  pancreatic  stone  removal  after  sphincterotomy  using  conventional  stone  baskets,  balloons  and 
mechanical or laser lithotripsy with success rates ranging from 27- 100%[68,69]. Endoscopic shock wave 
lithotripsy (ESWL) is an adjunct  to Endoscopic drainage[71,76].  Naso pancreatic  tube may be used for 
flushing out stones as well as for irrigation with citrate for chemodissolution. 
Endoscopic sphincterotomy
There are two methods to cut the pancreatic sphincter endoscopically[67].
1. A standard pull type sphincterotome (with or without guide wire) is inserted into the pancreatic 
duct and oriented along the axis of the pancreatic duct usually in    1  – 2 o’ clock position. The 
cutting wire should not extend more than 6 – 7 mm inside the duct and the maximum cut should not 
exceed 5 – 10 mm. 
2. Alternatively,  a needle knife sphincterotome can be used to perform the sphincterotomy over a 
previously placed pancreatic stent. 
Endoscopists are encouraged to remove pancreatic ductal stones in symptomatic patients or when the stones 
are located in the main duct head, body or both. The ability to remove a stone by Endoscopic methods alone 
is dependent on stone size, location, number, presence of downstream stricture, and the degree of impaction. 
Factors favouring complete stone removal:
1. Three or less stones 
2. Stones confined to the head or body of the pancreas
3. Absence of a downstream stricture 
4. Absence of impacted stones
Largest stones (more than 1 cm), stones above the strictures and calcified stones can be fragmented within 
the pancreatic duct by extra corporeal shock-wave lithotripsy (ESWL)[71]. Protein plugs are soft and pliable 
and can be extracted immediately after the sphincterotomy. Largest stones can also be fragmented by intra 
ductal laser lithotripsy or with electro hydraulic lithotripsy with the help of a pancreatoscope. 
Pancreatic Pseudocysts:
Pancreatic  pseudocysts  may  complicate  the  course  of  TCP  in  20  –  30  %  of  cases.  The  methods  for 
Endoscopic drainage of pseudo pancreatic cysts include Endoscopic cystogastrostomy, cystoduodenostomy, 
and trans papillary drainage[32,80,81]. Endoscopic therapy is associated with a high technical success rate 
of 80% of patients and surgical drainage is required in approximately 10% of these patients. 
Biliary Obstruction in Calcific Pancreatitis:
Biliary Obstruction can lead to cholangitis and eventually biliary cirrhosis. Intra pancreatic common bile 
duct strictures are reported to occur in 10% of patients with TCP[34,35]. Strictures are a result of fibrotic 
inflammatory restriction or compression by a pseudocyst. Plastic biliary stents are a useful alternative to 
surgery for short-term treatment of TCP induced CBD strictures and also high-risk surgical patients[82]. 
Future Role:
Endoscopic Management of TCP is technically feasible and should be considered as a valuable alternative to 
surgery in properly selected patients in proper hands. The future role of Endoscopic therapy will depend on 
evolving technology and the results of carefully performed randomized controlled trials that will address the 
clinical outcomes.
TABLE 1.1
CAMBRIDGE  CLASSIFICATION  OF  PANCREATOGRAMS  IN  CHRONIC 
PANCREATITIS.
TERM MAIN DUCT SIDE BRANCHES 
ADDITIONAL 
    ABNORMAL    FINDINGS
Normal Normal None -
Equivocal Normal Fewer than 3 -
Mild Normal 3 or more -
Moderate Abnormal 3 or more -
Marked Abnormal 3 or more One or more: large
Cavity (>10 mm), 
obstruction,
Filling defects, severe
Dilation, irregularity
________________________________________________________________________
Modified from Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: International 
definitions. Gut 1984; 25:1107-12. 
TABLE 1.2
ENDOSCOPIC  RETROGRADE 
CHOLANGIOPANCREATOGRAPHY 
FINDINGS IN CHRONIC PANCREATITIS.
_______________________________________________________________________
DEFINITE FINDINGS
Irregular dilation of the main pancreatic duct, branches, and fine pancreatic ducts
Calculi
Cysts communicating with the main pancreatic duct with abnormal findings
Obstruction of the main pancreatic duct with abnormal findings
ABNORMAL FINDINGS
Irregular dilation of the main pancreatic duct, branches, and fine pancreatic ducts alone
Cysts communicating with branch ducts
Obstruction or stenosis, or both, of the branches and fine pancreatic ducts 
Plugs (protein) within the ducts
REFERENCE FINDINGS
Simple dilation of the pancreatic ducts
Tortuosity of the main pancreatic duct
Localized stenosis of the main pancreatic duct
Rigidity of the pancreatic ducts
Coarse acinar opacification 
Stenosis of the pancreatic portion of the common bile duct
Note: The pancreatic ducts include the main pancreatic duct, branches, and fine pancreatic ducts. Irregular 
dilation indicates dilation associated with stenosis (mainly relative degrees of stenosis).
TABLE 1.3
ASSESSMENT OF THE DEGREE (SEVERITY) OF CHRONIC PANCREATITIS BY 
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FINDINGS 
                    DEGREE OF FINDINGS
                     ___________________________________________
FINDINGS      Mild (MI)        Moderate (MO)     Severe (SE)
Main pancreatic duct
  Irregular dilations - + ~ + +
+ + +
  Calculi - - +
  Cysts - - +
  Obstructions - - +
  Plugs + + +
Branches and fine pancreatic ducts
  Irregular dilations + + + + + +
  Calculi - - +
  Cysts + + + + +
  Obstructions + + + + +
  Plugs + + +
Note: Bold face terms specify findings that are definite for chronic pancreatitis. These  
findings have priority importance in the interpretation of pancreatograms.
* including Cystic dilation. 
TABLE 1.4
COMPARISON  OF  RADIOLOGICAL  FEATURES  OF  CALCULI  IN  TROPICAL 
PANCREATITIS AND IN ALCOHOLIC PANCREATITIS.
Radiological feature    Tropical   Alcoholic
Pancreatitis Pancreatitis
   (n = 89)    (n = 32)
_______________________________________________________________________
Distribution (%)        
Right of vertebrae        72        66
Over vertebrae        52        64
Left of vertebrae        70        82  
Right of vertebrae alone        20          6
Left of vertebrae alone        2.2        20
Size of largest calculus (%)
< 10 mm        65        18
5-10 mm          7        20
< 5 mm        28        62
Margins of calculi (%) 
Sharp / well defined        87        10
Irregular / hazy        13        90
Radio density (%)
+        50        94
+ +        75        12
+ + +        62        12
________________________________________________________________________
Reference: Chari S, Jayanthi V, Mohan V, Malathi S, Madanagopalan N, Viswanathan  
M.  Radiological  appearance  of  pancreatic  calculi  in  tropical  vs.  alcoholic  chronic  
Pancreatitis. J Gastroenterol Hepatol 1992; 7:42-44.
TABLE 1.5
DIFFERENCES IN THE ULTRASONOGRAPHIC APPEARANCES OF TROPICAL AND 
OTHER TYPES OF PANCREATITIS.
   Ultrasound    Tropical      Other
Characteristics Pancreatitis
Pancreatitis
Duct dilation 82% 52%
Presence  of calculi 77% 57%
Pancreatic atrophy 53% 5%
Altered echogenicity 59% 38%
Reference:  Bolordi L, Silvia LB, Gaiani S, et al. Sonography of chronic Pancreatitis.  
Radiol clin N Amer 1989; 27: 815-33.
TABLE 1.6
COMPLICATIONS OF TCP.
STRUCTURAL METABOLIC
Pseudocyst Narcotic addiction
Pancreatic abscess Cobalamin (vitamin B12
                                                                                    Malabsorption)
Pancreatic Ascites Sub cutaneous fat necrosis
Common bile-duct obstruction Bone pain
Duodenal obstruction Non diabetic retinopathy 
Splenic-vein thrombosis (Portal hypertension) Weight loss
GI bleeding Diabetes related.
Pancreatic cancer Poor quality of life.
TABLE 1.7
ENDOSCOPIC INTERVENTIONS FOR TCP.
Clinical Condition Endoscopic Therapy
Chronic Pancreatitis Endoscopic sphincterotomy ( bile duct or 
Pancreatic duct)
Pancreatic stricture dilation 
Pancreatic stone extraction 
Pancreatic  duct  stone  extraction  after  
ESWL
Bile duct stenting 
Pancreatic duct stenting 
EUS-guided celiac plexus block
Pancreatic pseudocyst Cysto enterostomy 
Trans papillary pancreatic stenting 
Pancreatic duct distruption / Ascites Trans papillary pancreatic stenting
TABLE 1.8
COMPLICATIONS DIRECTLY RELATED TO PANCREATIC DUCT STENTS
Occlusion that may result in Pain, Pancreatitis, or both
Migration into or out of duct 
Duodenal erosions 
Pancreatic infection
Ductal perforation 
Ductal; and parenchymal changes
Stone formation
  
AIM OF THE STUDY
TO STUDY THE ROLE OF
ENDOSCOPIC RETROGRADE
CHOLANGIO PANCREATOGRAPHY IN
TROPICAL CALCIFIC PANCREATITIS.
MATERIALS AND METHODS
A total of 123 consecutive patients (103M: 20F) in the age group of 13-54 years (mean age 29.8 years), 
diagnosed  as  Tropical  Calcific  Pancreatitis(TCP) in a tertiary referral  centre  for gastroenterological  and 
hepatobiliopancreatic  disorders.  Patients  referred  and  diagnosed  as  TCP  by  clinical,  radiological, 
biochemical,  Ultrasonographic,  CAT  Scan  Evaluation  (in  selected  cases)  underwent  diagnostic  ERCP 
between Jan 2000 to Dec 2003 in purview   of therapeutic ERCP. 
ERCP was done using the ED 3430-T AO 1206 Video duodenoscope (Pentax) with a 2.8mm channel(fig2.1) 
and a conventional fiberoptic duodenoscope (Model FD-34B, A01085,FD-34V, A01086 and JF-1T10, JF-
B4,110272 ) with 3.2mm channel. The Endoscopic suite is used in performing ERCP about  900 sq.ft is 
adequate  enough  to  handle  all  the  radiological  and  Endoscopic  equipment  as  well  as  the  necessary 
personnel. A high quality television monitor of 525 lines is used for fluoroscopic visualization. Hard copy 
was obtained using spot films. A 9” * 9” cassette is the most frequently used size. The focal spot of the X-
ray tube is 0.6mm. The X-ray tabletop moving in the horizontal plain to permit moving the sedated patient 
with minimal disturbance. Automatic tilting the X-ray table can help fill the intrahepatic bile-ducts at 15 
degree head-down position. It can be tilted upto 90-degree upright position best for examining GB after it is 
filled with contrast medium. The radiographic examination of pancreatic duct and biliary tree begins with 
the plain 14” * 14” spot film to include the upper abdomen. The radiographic exposure for both fluoroscope 
and film images at 80 KVP and 90 KVP for the larger patient. The magnification factor for the machine is 
36%.  This is useful for measurement of stone size and length of a stricture. 
Magnification factor = (Measured diameter of the duodenoscope) – (True diameter of the duodenoscope) / 
True diameter of the duodenoscope
Contrast: 
60% concentration for opacification of the biliary tree and pancreatic duct. Full strength contrast 60% was 
used initially for diagnostic cannulation under fluoroscopic control until the tail and some side branches are 
visualized. Care was taken not to acinarize into the pancreatic parenchyma (pancreatic acinarization). The 
contrast used is meglumine salt of diatrizoic acid of 60% w/v with iodine content of 282mg/ml available as 
20ml ampoules. 
The pancreatic duct filled up to the tail and with a bifurcation as a landmark. Normally the biliary tree, 
excluding GB should be completely drained of contrast medium within 45 minutes and the pancreatic duct 
should empty within 5 to 10 minutes. When the filling of pancreatic duct is the primary concern but also if 
opacification of the bile-duct is required it can be filled atleast to the third-order intrahepatic bile-ducts.
Positioning of the patient:
It is performed with the patient lying most prone position with head turned towards right, shallow oblique 
position with the left side down or left lateral swimmer’s position. 
ERCP Procedure:
ERCP was performed as an inpatient procedure. Written and informed consent was obtained in all patients. 
The patient was on  overnight fast and the procedure was preformed in the morning. A history of allergy to 
iodine  contrast was noted. Intravenous  sedation with 15 mg – 30 mg of Pentozocaine and / or 25 – 50 mg 
Promethazine was used. The patient was sedated with IV drugs via an IV Catheter inserted in the right 
forearm. A self-retaining mouth guard was placed and the patient was supported in a left lateral/semi prone 
position.
Hyoscine butyl bromide (Buscopan):
20 mg was given IV to relax the duodenum to inhibit duodenal peristalsis. Alternatively 0.5 mg glucagon 
may be used. Medication and contrast was drawn up in 20 ml disposable syringes and clearly labeled to 
avoid any mistake. 20 ml syringe with sterile water is useful for flushing the catheter prior to insertion of 
hydrophilic guide wire. 
ERCP Instrument:
ERCP done using the ED 3430-T, A 1206 Video duodenoscope(Pentax)with monitor(fig:2.2 & 2.3). It  is 
12.5 mm in diameter with a 2.8 mm channel. Other conventional fibreoptic scopes,FD-34V(pentax)
JF-B4,JF-1T 10(olympus) with 3.2mm channel were also used.
Personal protection:
Standard protection lead apron (0.2 mm to 0.5 mm lead) was used having front and back protection. A lead 
collar to protect the thyroid gland.
Accessories:
The cannula (6Fr Teflon tube which taper to a 5Fr tip). ERCP-1regular, ERCP-1-CT taper. Classic ERCP 
catheters are used for Endoscopic cannulation of the ductal system, injection of contrast and provides the 
ability to maintain wire guide access to the desired duct for the introduction of compatible devices. They are 
of 5.5 Fr in diameter require a minimum channel size of 2.8mm. A wire of 0.035” diameter can be passed 
through the catheter(fig 2.6).
Endoscopic sphincterotomy:
Routine  blood  counts  and  biochemistries  are  checked  and  coagulopathy  corrected  by   vitamin  K  IM 
injection or transfusion of fresh frozen plasma. Patient should be advised to stop intake of asprin or NSAID 
and coumadin for one week prior to elective sphincterotomy.
Standard pull type sphincterotome CT-25m cotton cannulatome (WC 1 monofilamentwire, fig: 2.7). The 
electrocautery wire, exposed only at the distal 1 to 2 cm of the catheter, is of differing lengths and 
constructed of either of a thin braided or monofilament solid wire, which can be seen at fluoroscopy. They 
accept 0.035” or smaller wire guides
Needle knife sphincterotome -HPC-2  with 4 mm exposure wire .
 The needle knife had reserved for high risk patients with a strong indication for accessing the ductal system 
when standard techniques failed. The needle extension on the HPC –3 may be adjusted by loosening the 
thumb screw or retracting the adjustable ring on the handle.
Guide wire (WC)
Teflon coated guide wire 
THSF-35-400   .035” (regular and heavy duty),400cm,480cm.
Hydrophillic wire   TM-400 -  .035” tracer wire (coated with hydropolymer terumo that makes the guide 
wire very slippery when in contact with water). 
Zebra wire     .035” in diameter,260cm,450cm.(Zebra wire made of nitinol and is a multipurpose guide wire 
that  can  be  used  for  accessing  pancreatic  duct,bile  duct,for  maintaining  proper  position  during 
sphincterotomy,for crossing the stricture,for mounting a 7-Fr stent directly over it and for exchanging over it 
various  catheters  and  other  accessories.It  does  not  kink  due  its  rigid  nature.the  tip  is  flexible  and 
atraumatic.It has stripes for movement detection(fig: 2.8).
Glide wire .035”,  .021” in diameter,260cm,450cm.(Nitinol  with polyurethane hydrophilic  coat  on entire 
length)
Stents
Pancreatic Stent Set (WC)
5Fr*7Fr   7,9,12 cm
Plastic stents are made up of Teflon Polyurethane or polyethylene. Pancreatic stents have many regularly 
spaced side holes(fig: 2.5). 
Stent pusher
The choice of stent pushers depends upon the size of the stent to be placed .ie  7 Fr for a 
7 Fr stent  and 10 Fr for a 10 Fr stent.
Dilators
CDGC-8.5-7.5 Graded dilators
Push-type dilating catheters one inserted over a guide wire to dilate strictures. They have a metallic ring that 
indicates the position of maximum diameter nearest to the dilator tip. Biliary dilation catheters (Soehendra, 
Cotton, Siegel-cohen & Van andel). Available in a variety of sizes from 6Fr to 11.5Fr requiring a minimum 
channel size ranging from 2.8 to 4.2mm.
Balloon Dilators
  Olbert biliary balloon dilators were used for dilating biliary strictures. They 
are available with various sizes and useful in dilating tight strictures(fig: 
2.5).
Diathermy unit
Olympus PSD-10
Electrosurgical unit to the “off” position when it is not in use. Any electrosurgical accessory constitutes a 
potential electric hazard to the patient and the operator. 
Adverse effects: Fulguration burns, nerve and/or muscle stimulation and cardiac arrhythmia. Utmost care 
was taken during operation.30W of cutting and10W of coagulation current was blended and used for electro 
surgical procedures and increased if needed.
Extraction basket
The extraction basket is used for the Endoscopic removal of stones. The basket is constructed of 
multifilament memory wire for shape retention. Contra indication includes an ampullary opening inadequate 
to allow the unimpeded passage of the stone and basket. The sheath of the WEB basket is 7Fr and requires a 
minimum channel size of 2.8mm.
RESULTS
Of 123 patients (103M: 20 F) with TCP were undergone a total number of 135 ERCP 
sessions. Diagnostic ERCP was performed in all 123 patients out of which 62/123 (50.4%) 
received  pancreatic  endotherapeutic  interventions  and  28/123 (22.7%) received  biliary 
Endotherapy. The bile duct was cannulated in 88/123 (71.5%) patients and pancreatic duct 
in all patients (100%) and both ducts in 88/123 (71.5%) patients.
ERCP identified a wide variety of changes in the MPD and its side branches. It includes 
ductal irregularities 116/123 (94.3%), ductal dilatation 110/123 (89.4%), ductal strictures 
85/123 (69.1%), ductal beading 56/123 (45.5%), cavities 18/123 (14.6%), Sacculation and 
Ectatic  changes  including  chain  of  lakes  appearance  in  12/123  (9.7%)  patients. 
Complications such as pseudocysts were noted in 11/123 (8.9%) and suspected pancreatic 
malignancy in 2/123 (1.6%).
 A total of 62/123 (50.4%) patients had pancreatic Endotherapy of which 58/62 (93.5%) 
patients required Endoscopic pancreatic sphincterotomy. 37/62 (59.6%) patients received 
pancreatic stenting and 26/62 (45.1%) had undergone stricture dilatation.
Concomitant biliary changes in the form of biliary stricture was noted in 32/123 (26%) 
patients. Biliary Endotherapy such as biliary sphincterotomy in 21/32 (65.6%) patients, 
biliary dilatation 18/32 (56.2%) patients and biliary stenting were done in 16/32 (50%) 
patients. 
16 patients received dual system Endotherapy of which 7/16 patients had stenting of both 
systems. Biliary stenting was done to facilitate pancreatic duct cannulation in 6 patients 
and removed after pancreatic Endotherapy. 
Procedure related complications  were noted in 6/123 (4.8%) patients  and no mortality 
occurred. Refer Table 2.1.
TABLE 2.1
DIAGNOSTIC ERCP
Pancreatic Biliary
Ductal calculi - 120/123, (97.5%) Biliary stricture - 32/123, (26%)
Ductal irregularities - 110/123, (89.4%)
Ductal strictures - 85/123, (69.1%)
Ductal beaded appearance - 56/123, (45.5%)
Cavities - 18/123, (14.6%)
Sacculation and ectatic changes - 12/123, (9.7%)
Pseudocysts – 11/123, (8.9%)
Malignancy – 2/123, (1.6%)
THERAPEUTIC ERCP
Pancreatic Biliary
Endotherapy – 62/123, (50.4%) Endotherapy – 28/123, (22.7%)
Pancreatic sphincterotomy – 58/62, (93.5%) Biliary sphincterotomy – 21/32, (65.6%) 
Pancreatic stenting – 37/62, (59.6%) Biliary dilatation 18/32, (56.2%)
Stricture dilatation – 26/62, (41.9%) Biliary stenting 16/32, (50%)
OTHERS
Dual system Endotherapy – 16 cases
Dual system stenting – 7 cases
Biliary stenting to facilitate PD cannulation – 6 cases
Complications – 6/123, (4.8%)
DISCUSSION
Tropical Calcific Pancreatitis is a special type of Chronic Pancreatitis prevalent in many 
parts of the Asia-Pacific region. The largest series is by Geevarghese from the State of 
Kerala, Southern India [5]. This present study is about 123 Tropical Calcific Pancreatitis 
patients (103M: 20 F) who were from different parts of the State of Tamil Nadu. Few 
patients (6/123) were from outside of this state. History significant Cassava Consumption 
not noted in our series since this is not the staple diet in Tamil Nadu. As noted in other 
series abdominal pain is the predominant symptom in the series (100%) of patients. The 
duration  of  pain  ranges  from 2 to  12.6  years  with  a  mean  duration  of  3.8  years.  No 
significant steatorrhoea noted in this series. Since the representing population of patients 
from the lower social economic strata and it is related poor fat intake. Diabetes mellitus 
was  noted  in  3.2% of  patients.  2.6% of  patients  received  insulin  for  control.  Lower 
incidence of Diabetes Mellitus in this series is in contrast to the studies from the same part 
of the State. It is primarily due to referral bias. Since this series is from gastroenterological 
special unit and other studies that reports the higher incidence of Diabetes Mellitus in TCP 
is from diabetes special clinic [98].
Most of the patients in this series have a lean body habitus with an average of BMI of 
19.8. None of the patients in this series were obese as defined by BMI is > 30. 
On screening pancreatic calcification is noted 120/123 (97.5%) patients. Compared with 
other series the percentage of patients with calcification in this series is high. This is again 
due  to  the  referral  bias  and most  of  our  patients  have  advanced diseased  and mostly 
referred from other hospitals for tertiary care.
DIAGNOSTIC ERCP IN TCP:
Diagnostic ERCP in South India TCP patients have been documented since 1985 [6-10]. 
The diagnostic role and spectrum of ERCP changes in TCP can be considered as follows:-
a. To identify sacculation, ecstasia and beading 
b. To identify  ductal  calculi  in  relation  to  its  size,  number,  location,  distribution, 
density variation and impaction 
c. To identify pancreatic complications ascites or pleural effusion. 
d. To differentiate and deliniate the plain X-ray findings of pancreatic calcification 
with the reference to the ductal or parenchymal location
e. To study biliary changes like stricture, compression and cholangitis related to TCP 
and its sequlae.
f. To identify the suspicious ductal malignant transformation
g. To formulate Endoscopic therapeutic interventions
h. To offer guidelines to consider surgical interventions
i. To evaluate symptomatic post operative cases
j. To plan Endosonographic evaluation
k. To collect pure pancreatic juice for research analysis
l. To plan manometric evaluation of the Sphincter of Oddi in selected situation.
In this series ERCP was done in 123 cases of Tropical Chronic Pancreatitis over a period 
of 3 years from 2000-2003 in the age group ranging from 13 - 54 years with a mean age of 
29.8  years . The pancreatic duct was cannulated in all patients (100%) and the bile-duct 
cannulated in 88/123 (71.5%) and both in 88/123 (71.5%). The cannulation rate in Philip 
Augustine series [40 ] involving 130 patients was 87% for the pancreatic duct and 82% for 
the bile duct. The higher pancreatic cannulation rate was aided by the greater use of needle 
knife precut sphincterotomy. Failure to cannulate in TCP was due to: -
a. Impacted ductal stones
b. Tumour blocking the head portion of the duct
c. Distorted loco regional anatomy
d. Papillary stenosis
e. Compression by large pseudocysts
f. Large pancreatic calculi in the head region 
The unrelated factors like periampillary diverticulae, ectopic ampulla, post gastric surgery 
states etc., add to the technical difficulties in cannulation. When ERCP fails ultra sound 
guided  percutaneous  pancreatic  ductography  (PPD)  and  percutaneous  transhepatic 
cholangiography (PTC) can be considered in selected cases according to the clinical stage 
and  situation.  In  this  series  cases  with  inability  to  cannulate  pancreatic  duct  was  not 
included.
Ductal changes:
ERCP identifies a wide variety of changes in the main pancreatic duct (MPD) and its side 
branches. It includes: - Ductal irregularities 116/123 (94.3%), ductal dilatation 110/123 
(89.4%), ductal strictures 85/123 (69.1%), ductal beaded appearance in 56/123 (45.5%), 
cavities in 18/123 (14.6%), sacculation and ectatic changes in 12/123 (9.7%) were noted.
Ductal strictures are localized having a short segment and may be single or multiple that 
occurs mostly in the head, genu and body portion. Long segment stricture (> 10 mm) is 
due to possible ductal malignant transformation. Strictures alternating beading to chain of 
lakes appearance, commonly seen in CP in the west is rare in TCP. It is noted in 5/123 
(4%) patients. Filling defects are mostly due to ductal calculi 120/123.  Ductal disruption 
and fistulae were seen in 3 cases. Ductal block had been documented in 108/123 (87.8%), 
predominantly due to intraductal calculi with or without strictures. The other causes of 
ductal block in TCP include malignant mass  + stricture, abscess/cyst and inflammatory 
mass. Ductal changes are focal when the involvement is less than one third and diffuse 
when the involvement is more than one third. In our series the ductal  dilatations were 
graded as:-
a. Less than 10mm (11.6%)
b. 11-20mm (68.1%)
c. More than 20mm (20.3%)
a. Ductal dilatations up to and more than 50mm have been noted by Philip Augustine 
in Kerala suggesting that the largest pancreatic ducts are probably seen in TCP 
cases [11].  In 3.6% of our series grossly dilated ectatic  changes involving the 
MPD and many side branches were noted in various sizes and forms resembling 
bronchiectasis and hence designated as Pancrectasis of TCP [30]. In cases where 
the entire ductal system has been opacified, the size and volume of the filled ductal 
system can be visually assessed. 
Endoscopic methods and anastomotic surgeries are better suited for large ductal groups 
and resective surgery may be more ideal for the minimally dilated group. In addition serial 
analysis  of  ductal  system  changes  will  identify  the  ongoing  changes  and  the 
complications, which alter the ductal morphology and continuity.
DUCTAL CALCULI:
Ductal calculi in TCP have a documented incidence of 72-100% [5,7].In our series it was 
present in 120/123(97.5%)of patients. The size of the calculi varies from 3-30mm. In this 
series the calculi were graded as: -
a. Less than 5mm (11.8%)
b. 6-10mm (36.4%) 
c. 11-20mm (48.6%)
d. And more than 20mm (3.2%)
The calculi were sharp and well defined in (89.2%), irregular and hazy in (11.8%) and the 
distributions of calculi were Head region (69.8%), body (62.3%), tail (7.9%) and universal 
in  (21.71%).  Occasionally  dumb-bell  shaped  extension  of  the  calculi  into  the  side 
branches have been noted. These stag-horn shaped calculi  post technical difficulties in 
removal  and  mostly  unsuccessful.  Most  of  the  calculi  were  very  dense  and  can  be 
differentiated from alcoholic calcific Pancreatitis [9]. Progressive displacement of calculi 
on serial studies may provide a clue to the presence of either an enlarging tumour or a 
pseudocyst.  ERP  has  greater  sensitivity  in  differentiating  between  the  ductal  and  the 
parenchymal  calcification identified in the plain X-ray.  The calculi  in TCP are always 
intraductal either in the MPD, side branches or both. 
PANCREATIC COMPLICATIONS:
ERCP in TCP identifies some of the complications, which are also seen in the other forms 
of  CP.  Communicating  pancreatic  pseudocysts  were  seen  in  6/123  (4.8%)  and  non 
communicating pseudocysts in 5/123 (4%) cases. Sarles has reported the preservation of 
pancreatic ductal epithelium for a longer time in TCP and hence the decreased incidence 
of cyst  formation in these cases[56]. Pancreatic ductal disruptions in TCP are rare and 
when present  ERCP has  a definite  role,  which is  of diagnostic  as well  as  therapeutic 
significance. It was noted in 3 cases in this present series. 
BILIARY CHANGES: 
Biliary changes once considered very rare in tropical calcific Pancreatitis has now being 
increasingly documented[34,35]. Reported incidents ranges from 10-30%. In this series 
biliary changes are noted in 32/123 (26%) cases. TCP related benign biliary stricture in 30 
cases and extraneous compression in 2 cases. In a study by Philip Augustine involving 150 
cases of TCP, obstructive jaundice was detected in 16 cases[13]. Benign stricture of CBD 
in  4 cases  (25%),  pseudocysts  in  the  head  of  the  pancreas  in  3  patients  (18.7%) and 
cholangitis was present in 2 cases (12.5%). Large pancreatic calculi in the head region is 
another cause for biliary obstruction in 2 cases of TCP in this present series. 
PANCREATIC MALIGNANCY:
TCP is considered as a premalignant condition[39]. The reported incidence ranges from 
5-8.3%.  It  is  predominantly  a  ductal  adenocarcinoma  and  hence  ERCP  is  useful. 
Augustine  and  Ramesh  have  put  forth  a  series  of  TCP  patients  in  which  they  have 
compared retrospectively various parameters between patients with tropical Pancreatitis 
(82 patients) and patients with super imposed malignancy concluded that mass lesion on 
ultrasound and ductal obstruction in ERCP were significantly associated with the presence 
of pancreatic  cancer[13].  In our series suspicion of malignancy in 2 (1.6%) cases, the 
diagnostic ERCP findings were:- double duct sign in 1 patient, abrupt cut off of MPD in 1 
patient and long segment stricture (> 10mm) in 1 patient .Shemesh et al have shown that 
pancreatic  duct  stricture  of  more  than  10mm  in  length  could  diagnose  pancreatic 
carcinoma in all 10 patients with coexisting Pancreatitis[38].
Diagnostic ERCP in TCP is useful in evaluating symptomatic patients following surgical 
procedures  like  pancreaticojejunostomy[26].  Collection  of  pure  pancreatic  juice  after 
stimulation with secretin and caerulin is possible[40]. ERCP with manometric evaluation 
is  helpful  in  studying  the  sphincter  pressure  in  TCP.  Based  on  the  diagnostic  ERCP 
findings therapeutic options like non-surgical, endoscopic and surgical can be planned and 
implemented. 
Based on the observations of diagnostic ERCP performed in view of possible therapeutic 
implications in this series have been grouped as follows:-
Group 1 – Ductal changes:
Irregularities  stricture,  dilatation,  filling  defects,  blocks,  sacculation,  gross  ductal 
dilatation involving the entire ductal system.
Group 2 – Calculi in MPD and side branches:
Size, location, margins, Density, distribution, type, Impaction and obstruction.
Group 3 – Complications:
Communicating  pseudocysts,  abscess,  ductal  disruption,  pancreatic  ascites  and 
pancreatic effusion.
Group 4 – Malignant transformation: 
Malignant stricture, mass, obstruction.
Group 5 – Biliary changes:
Biliary stricture, biliary compression, cholangitis.
Group 6 – Categorization of therapy:
Endoscopic, surgical, combined.
Group 7 – Considerations for other evaluations:
Endosonogram,  manometry,  pancreatic  function  studies  and  postoperative 
evaluation.
THERAPEUTIC ERCP IN TCP:
The  diagnostic  spectrum  of  ERCP  in  TCP  provides  a  road  map  in  selecting 
endotherapeutic interventions which is of clinical significance in relieving pain as well as 
exocrine insufficiency[23,30,40,41,43]. In India the endotherapeutic work of Nageshwara 
Reddy,  Philip M, Krishna Rao, Deepak Bhasin, Nagarjuna, Subash, Maydeo, Nair and 
many others have established the utility and benefits of pancreatic Endotherapy in TCP. 
The main objectives of Endotherapy in TCP are :-
a. To relieve pain
b. To relieve pancreatic ductal obstruction
c. Removal of stones
d. To facilitate drainage of pancreatic juice flow
e. To improve pancreatic exocrine insufficiency
f. To treat complications
g. To avoid or postpone surgery. 
ENDOTHERAPEUTIC PROCEDURES:
The different endotherapeutic procedures available for treating TCP patients in different 
clinical situations are classified into 3 groups:-
a. Pancreatic Endotherapy
b. Concomital biliary Endotherapy
c. Dual system Endotherapy.
ENDOTHERAPY FOR PAIN:
Sphincterotomy (pancreatic,  biliary or  both),  pancreatic  stenting  and Endoscopic  stone 
removal will significantly remove pain in TCP[25,60,62,67]. Biliary ductal hypertension 
secondary to TCP is another cause of pain even in the absence of jaundice and cholangitis. 
In  that  case,  biliary  Sphincterotomy  and  decompression  can  give  significant  relief  of 
pain[65]. Biliary and Pancreatic Sphincterotomy + pancreatic stenting were the common 
procedure done in this series (93.5%). Significant pain relief was achieved in (100%) of 
cases.  Complications  like  pseudocysts,  abscess,  malignancy  and  pancreatic  ascites 
contribute  to  pain,  which  may  be  relieved  by  pancreatic  Endotherapy  in  selected 
cases[12,21,32,44,59]. 
ENDOTHERAPY FOR PANCREATIC STRICTURES:
The stricture in TCP can be dilated by Endoscopic methods using push dilators/balloon 
dilators  in  graded  sizes  after  a  preliminary  sphincterotomy.  In  this  series  stricture 
dilatation  was  done  in  26/62 (41.9%) cases.  Even if  Stricture  dilatation  is  successful, 
placement of plastic stent following dilatation can give very good results[41,42]. It was 
done in all 26 (100%)  cases. Failure to dilate the stricture in TCP is due to: -
a. Inability to cannulate the PD and place the guide wire (35.6%)
b. High grade and tight strictures (19.8%)
c. Strictures with  impacted  stones (28.7%)
d. Multiple strictures with a beading (12.1%)
e. Malignant long segment strictures (1.2%)
f. Inaccessible PD due to loco regional anatomical distortion (2.6%)
McCarthy et al have reported that pain relief that following dilatation and stenting in 70% 
of their patients[95].In our series patients with pancreatic strictures for whom pancreatic 
stenting was done were followed up for 6-36months and all of them had significant pain 
relief. 
PANCREATIC STENTING (37):
Pancreatic stenting in TCP can be considered under the following circumstances:
a. With Sphincterotomy 35/37 (94.5%) patients
b. Without Sphincterotomy 2/37 (5.4%) patients
c. After stricture dilation 26/37 (70.2%)patients
d. After partially cleared pancreatic duct 10/37 (27%) patients
e. Stones in PD (100%)
f. In communicating pseudocysts 2/6 (33.3%)patients
g. In pancreatic disruption 2/3 (66.6%) patients
h. In pancreatic malignancy in TCP who are unfit for other procedures 1/37 (2.7%) 
patients
Amsterdam Plastic stents  are usually deployed in sizes ranging from 7Fr – 10 Fr and 
length ranging from 5 – 12cm. Stenting is usually successful[71,72]. In our series distorted 
ductal  anatomy  prevented  complete  deployment  in  6  (4.8%) of  patients.  Spontaneous 
migration  was  noted  in  1  patient.  Pancreatic  stenting  done  in  37  cases  in  this  series 
provide  a  significant  pain  relief  in  (96.4%) of  cases.  Mild  post  procedural  abdominal 
discomfort was noted in (2.1%). Hence pancreatic stenting is an effective, relatively safe 
in experienced hands and also definitely indicated in symptom relief[30,42,43].The stent 
can be left in place until symptoms or complications. Alternatively it can be left in place 
for a period of 6 to 12 months with periodic exchanges[72,73]. Most of the patients in our 
series (98.2%) had no complications when followedup for more then 24 months.
CONCOMITANT BILIARY ENDOTHERAPY:
10-30% of TCP patients develop intra pancreatic CBD stricture mostly due to fibrosis in 
the  head  of  the  pancreas  and  rarely  due  to  pseudocysts  compression[34,90].  Not  all 
radiological strictures need treatment. Biliary drainage is definitely indicated in patients 
having jaundice or cholangitis. In asymptomatic patients it is indicated if SAP is > 2 times 
normal  for  >  4  weeks  in  a  patient  with  stricture.  Biliary  ductal  hypertension  in  TCP 
presenting with pain responds to sphincterotomy and decompression. A study by Marc F, 
Catalano et al have concluded that multiple simultaneous stent pack technique appear to
be superior to single stent placement and may provide good long-term benefit and may 
obviate the need for surgical diversion procedures [86]. In our series biliary changes were 
observed in 32/123 (26%) of cases and concomitant biliary therapy was done in 28/32 
(87.5%) cases with good relief. It included biliary sphincterotomy in 21/32(65.6%) cases, 
biliary stricture dilatation in 18/32(56.2%) cases, biliary stenting in 16/32(50%) cases. In 
5/16 (31.2%) cases multiple  stents were deployed and this CBD stent packing method 
gave very good relief and response in this series. Significant biliary decompression was 
achieved  in  26/28  (92.8%)  cases  were  documented  by  clinical  and  biochemical 
parameters. Metal stents were not used in this study due to benign nature of the disease 
and cost[84,85]. Endoscopic drainage has a good short-term outcome and also long-term 
outcome with sustained relief with routine plastic stents 10/16 (62.5%) cases in a mean 
follow-up of 2-4 years.     
ENDOSCOPIC PANCREATIC STONE EXTRACTION:
Successful stone extraction can give a gratifying symptomatic relief of pain but technical 
difficulty  and  recurrence  are  problems  to  be  addressed.  A  study  by  Rosch  et  al,  a 
multicentric retrospective study of 758 patients of CP who received Endotherapy alone 
complete technical success could be achieved in 69%[76]. Outcome in stone and stricture 
groups  was  same.  Small  ductal  calculi  can  be  endoscopically  removed.  Endoscopic 
pancreatic  sphincterotomy  is  considered  as  the  corner  stone  [65,67].  Successful  stone 
extraction  after  sphincterotomy  depends  on  size,  number,  location  and  presence  of 
associated strictures. Stones < 10mm located in head and body and 3 or less in number 
had a greater clearance rate.  Ductal  calculi  upto 5-7mm can be removed with Dormia 
baskets  .  Balloons  are  likely  to  be  ruptured  by  the  sharp  fragmented  spicules.  Large 
impacted  stones  (1-1.5cm or  more)  need initial  lithotripsy (electroshock wave,  electro 
hydraulic, mechanical or laser) followed by Endoscopic methods by flushing or balloon 
retrieval.  Lithotripsy  techniques  were  not  used in  our  series  due  to  technical  reasons. 
Removal of stones attempted in (29.1%) cases .In 28(23.3%)cases stones that less than 
10mm were removed. 
ENDOSCOPIC ENTERAL / TRANS PAPILLARY DRAINAGE:
Pancreatic  pseudocysts  complicate  the course of TCP in  20-30% of  cases[81,82].  The 
indications  for  pseudocysts  are  the  presence  of  symptoms,  cyst  enlargement,  or 
complications.  Large  non-communicating  bulging  pseudocysts  are  indications  for 
Endoscopic  enteral  drainage  (Cystogastrostomy  /  cystoduodenostomy).  However  the 
incidence and literature documentation in TCP are anecdotal[90]. Trans papillary drainage 
can be done for large communicating pseudocysts. In this series Endotherapy in the form 
of trans papillary drainage was done for 2/6 (33.3%) cases of communicating pseudocysts. 
Internal pancreatic fistulas are an uncommon complication in TCP. These manifest either 
as  pancreatic  ascites  or  hydrothorax.  Trans  papillary  pancreatic  ductal  stenting  is  an 
effective pancreatic Endotherapy[31,79,80,90]. In this series 2/3 (66.6%) cases had trans 
papillary pancreatic stenting for pancreatic ductal disruption.
 
DUAL SYSTEM ENDOTHERAPY:
Simultaneous  and sequential  Endotherapy  of  pancreatic  and  biliary  system in  TCP is 
necessary  for  technical  and  therapeutic  issues  especially  in  complicated  cases  with 
malignancy and double duct sign[24] This was done in 16 cases in this series and dual 
system stenting in 7 cases. 
Therapeutic ERCP in TCP:
ERCP has therapeutic potential  and has got a dominating role in treating symptomatic 
TCP  patients.  Based  on  observations  and  experiences  in  our  series,  the  role  and  the 
limitations of therapeutic ERCP in TCP patients can be approached and categorized into 
the following groups summarized below: -
Group 1: - Endotherapy for pancreatic duct related disorder like calculi, stricture 
and ductal hypertension.
Group  2:  -  Endotherapy  for  pancreatic  complications  like  communicating 
pseudocysts and ductal disruption.
Group 3: - Endotherapy for concomitant biliary changes like biliary stricture, biliary 
compression, obstructive jaundice, and cholangitis.
Group 4: - Endotherapy for pancreatic ductal malignancy.
Group 5: - Endotherapy for symptomatic postoperative cases.
Group 6: - Endotherapy is not possible due to TCP related locoregional problems.
CONCLUSIONS
1. Tropical  Calcific  Pancreatitis  is  a  very  fertile  area  for  applying  different 
Endoscopic Retrograde Cholangio Pancreatographic interventions.
2. Diagnostic Endoscopic Retrograde Cholangio Pancreatography provides a road 
map for  planning for different endotherapeutic procedures.
3. In Tropical Calcific Pancreatitis the calculi are always intra ductal and mostly 
multiple,  dense  and  large  and  hence  pose  great  technical  difficulties  for 
therapeutic Endoscopic Retrograde Cholangio Pancreatography.
4. Pancreatic  stenting  is  an  effective  endotherapeutic  procedure  for  the 
symptomatic  relief  of  pain,  improves  ductal  drainage  and  quality  of  life  in 
Tropical Calcific Pancreatitis patients. 
5. A new practically useful classification of diagnostic and therapeutic Endoscopic 
Retrograde  Cholangio  Pancreatography  in  Tropical  Calcific  Pancreatitis  have 
been proposed for easy approach and planning therapy (subash classification).
6. Diagnostic  Endoscopic  Retrograde  Cholangio  Pancreatography  before 
therapeutic  Endoscopic  Retrograde  Cholangio  Pancreatography  provides  a 
learning curve for future therapeutic endoscopists.
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Grade 
IV  
          
18  Ms.Vani  F  16  
Grade 
IV  
          
19  Mr.Mohan  M  31  
Grade 
IV  
          
20  Mr.Loganathan  M  38  Grade III  
          
21  Mr.Murugan  M  29  Grade III  
          
22  Mr.Padmanabha  M  27  
Grade 
IV  
          
23  Mr.Rajesh  M  25  
Grade 
IV  
          
24  Mr.Kamaraj  M  35  
Grade 
IV  
          
25  Mr.Swaminathan  M  31  
Grade 
IV  
          
26  Mr.Kuppusamy  M  40  
Grade 
IV  
          
27  Mr.Ramasamy  M  37  
Grade 
IV  
          
28  Mr.Purushottaman  M  24  
Grade 
IV  
          
29  Mr.Swaminathan  M  31  
Grade 
IV  
          
30  Ms.Rubavathy  F  14  
Grade 
IV  
          
31  Mr.Mohan  M  36  
Grade 
IV  
          
S.No  Name  Gender  Age  Severity  
32  Mr.Chandran  M  46  
Grade 
IV  
          
33  Mr.Periyasamy  M  13  
Grade 
IV  
          
34  Mr.Saravanan  M  30  
Grade 
IV  
          
35  Mr.Chandrasekar  M  44  
Grade 
IV  
          
36  Mr.Gnanaraj  M  48  
Grade 
IV  
          
37  Mr.Govindaraj  M  49  
Grade 
IV  
          
38  Mrs.Parvathy  F  35  Grade III  
          
39  Mr.Murugesan  M  35  
Grade 
IV  
          
40  Mr.Senthil  M  13  
Grade 
IV  
          
41  Mr.Mani  M  40  
Grade 
IV  
          
42  Mr.Seethapathy  M  36  
Grade 
IV  
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43  Mrs.Lakshmi  F  55  
Grade 
IV  
          
44  
Mr.Srinivasa 
Perumal  M  30  
Grade 
IV  
          
45  Mr.Babu  M  39  
Grade 
IV  
          
46  Mr.Doss  M  38  
Grade 
IV  
          
47  
Mr.Venkatesh 
Kumar  M  31  
Grade 
IV  
          
48  Mr.Ekambaram  M  45  
Grade 
IV  
          
49  Mr.Venkateshwar  M  31  Grade III  
          
50  Mr.Samrajiam  M  32  
Grade 
IV  
          
51  Mr.Bakthavatchalam  M  37  
Grade 
IV  
          
52  Mrs.Kasthuri  F  42  
Grade 
IV  
          
53  Mr.Kirubakaran  M  41  
Grade 
IV  
          
54  Mr.Srinivasan  M  30  
Grade 
IV  
          
55  Mr.Damodaran  M  30  
Grade 
IV  
          
56  Mr.Gunasekar  M  23  
Grade 
IV  
          
57  Mr.Baburaj  M  32  
Grade 
IV  
          
58  Mr.Kumar  M  21  
Grade 
IV  
          
59  Mr.khader  M  32  GradeIV  
          
60  Mr.Murugesan  M  32  
Grade 
IV  
          
61  Mr.Kaliappan  M  18  Grade  
IV
          
62  Mr.Srinivasan  M  40  
Grade 
IV  
          
63  Mr.Munisamy  M  42  
Grade 
IV  
          
64  Mrs.Irfana Begum  F  25  
Grade 
IV  
          
S.No  Name  Gender  Age  Severity  
65  Mr.Baskar  M  30  
Grade 
IV  
          
66  Mr.Edward  M  20  
Grade 
IV  
          
67  Mr.Selvaraj  M  38  
Grade 
IV  
          
68  Mr.Kesavan  M  25  
Grade 
IV  
          
69  Mr.Mohan  M  38  
Grade 
IV  
          
70  Mr.Karthik  M  24  Grade III  
          
71  Mr.Babu  M  34  
Grade 
IV  
          
72  Mr.Sekar  M  37  
Grade 
IV  
          
73  Mr.Baskar  M  16  
Grade 
IV  
          
74  Mr.Sathiyaraj  M  17  
Grade 
IV  
          
75  Ms.Vijaya  F  20  
Grade 
IV  
          
76  Mr.Murugan  M  32  
Grade 
IV  
          
77  Mr.Perumal  M  26  
Grade 
IV  
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78  Mr.Baskar  M  16  GradeIV  
          
79  Mr.Parasuraman  M  37  GradeIV  
          
80  Mr.sankar  M  30  GradeIV  
          
81  Mr.kandasamy  M  32  GradeIV  
          
82  Mr.swaminathan  M   31  GradeIV  
            
83  Mr.kandasamy  M  20  GradeIV  
          
84  Mr.thirumurugan  M  16  GradeIV  
          
85  Mr.balachandran  M  27  GradeIV  
          
86  Mr.Kalaiarasi  F  29  GradeIV  
          
87  Mr.Mahendran  M  37  
Grade 
IV  
          
88  Mr.Senthilvel  M  32  
Grade 
IV  
          
89  Mr.Venkateshwaran  M  35  
Grade 
IV  
          
90  Mrs.Vasantha  F  46  
Grade 
IV  
          
91  Mr.Kathiresan  M  18  
Grade 
IV  
          
92  Mr.Chandrasekar  M  30  
Grade 
IV  
          
93  Mrs.Anusha  F  22  
Grade 
IV  
          
94  Mr.Rajesh Kumar  M  15  
Grade 
IV  
          
95  Mr.Mani  M  32  
Grade 
IV  
          
96  Mrs.Sulochana  F  50  
Grade 
IV  
          
97  Mr.Prasanth  M  19  
Grade 
IV  
          
S.No  Name  Gender  Age  Severity  
98  Mr.Sathyaraj  M  17  
Grade 
IV  
          
99  Mr.Bamanam  M  45  
Grade 
IV  
          
100  Mr.Shanmugam  M  35  
Grade 
IV  
          
101  Mrs.Loudumary  F  25  
Grade 
IV  
          
102  Mr.Rajan  M  18  
Grade 
IV  
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103  Mr.Kotteswaran  M  28  
Grade 
IV  
          
104  Mr.Muthuraman  M  54  
Grade 
IV  
          
105  Mr.Manikandan  M  10  
Grade 
IV  
          
106  Mr.Kalanjium  M  42  
Grade 
IV  
          
107  Mr.Raveendran  M  18  
Grade 
IV  
          
108  Mr.Sivaperumal  M  30  
Grade 
IV  
          
109  Ms.Veerammal  F  14  
Grade 
IV  
          
110  Mr.Kasi  M  32  
Grade 
IV  
          
111  Mr.Kuppuraj  M  14  
Grade 
IV  
          
112  Mr.Devarajan  M  45  
Grade 
IV  
          
113  Mr.Loganathan  M  31  
Grade 
IV  
          
114  Mr.Saravanan  M  15  Grade  
IV
          
115  Mr.Ramanathan  M  14  
Grade 
IV  
          
116  Mr.kandasamy  M  32  
Grade 
IV  
          
117  Mr.Sekar  M  30  
Grade 
IV  
          
118  Mrs.Jasmine  F  21  
Grade 
IV  
          
119  Mr.thirumalai  M  36  
Grade 
IV  
          
120  Mr.muthusamy  M  23  
Grade 
IV  
          
121  Ms.muniamma  F  17  
Grade 
IV  
          
122  Mr.Arun  M  31  
Grade 
IV  
          
123  Mr.Doss  M  30  
Grade 
IV  

